Variable | CPC 3–5 (n = 140) | CPC 1–2 (n = 64) | P |
---|---|---|---|
Patient demographics | Â | Â | Â |
Age (years) | 61 [48–69] | 53 [46–62] | 0.02 |
Male sex, n (%) | 102 (73) | 54 (84.5) | 0.14 |
Body mass index (kg/m2) | 25.5 [22–29.5] | 26.4 [23.1–28] | 0.71 |
Charlson comorbidity index | 1 [0–1] | 0 [0–1] | 0.31 |
OHCA characteristics | Â | Â | Â |
Location of OHCA, n (%) | Â | Â | 0.005 |
Public place | 36 (26) | 29 (45.5) | Â |
Private place | 104 (74) | 35 (54.5) | Â |
Witnessed OHCA, n (%) | 109 (78) | 59 (92) | 0.02 |
Bystander CPR, n (%) | 60 (43) | 50 (78) | <0.001 |
Arrest rhythm, n (%) | Â | Â | <0.001 |
Initial VF/VT | 47 (33.5) | 44 (69) | Â |
PEA/asystole | 93 (66.5) | 20 (31) | Â |
No-flow time (min) | 6 [1–10.5] | 0 [0–1] | <0.001 |
Low-flow time (min) | 23 [15–30.5] | 16 [10–25] | 0.003 |
On-scene epinephrine dose (mg) | 3 [1.5–5] | 1 [0–3] | <0.001 |
Laboratory values at ICU admission | Â | Â | Â |
Arterial lactate (mmol/L) | 5 [2.5–8.4] | 2 [1.5–4.3] | <0.001 |
Creatinine (µmol/L) | 113 [90–149] | 92 [75–111] | <0.001 |
Troponin (µg/L) | 0.8 [0.1–8] | 1.7 [0.3–16] | 0.07 |
Leukocytes (g/L) | 14.5 [11–19.5] | 15 [11.5–20] | 0.53 |
Neutrophils (g/L) | 11.5 [8–15] | 13 [9–17] | 0.15 |
I/T-G ratio (%) | 1.5 [0.5–2.5] | 0.5 [0.3–0.9] | <0.001 |
Severity scores | Â | Â | Â |
SOFA on day 1 | 11 [8.5–14] | 9.5 [7–11] | 0.001 |
SAPS II on day 1 | 74 [61–85] | 63.5 [50–72] | <0.001 |
OHCA score | 38.5 [22–46] | 5 [–3–18 | <0.001 |
CAHP score | 184.5 [156–210] | 144 [113–165] | <0.001 |
Hospital data | Â | Â | Â |
Admission temperature (°C) | 35 [34–35.5] | 35 [34.5–36] | 0.20 |
Therapeutic hypothermia, n (%) | 75 (53.5) | 55 (86) | <0.001 |
Early coronary angioplasty, n (%) | 29 (20.5) | 33 (51.5) | 0.003 |
Postresuscitation shock, n (%) | 79 (56.5) | 28 (44) | 0.09 |
Hospital length of stay (days) | 5 [3–9] | 16 [12–21] | <0.001 |